is it normal to gain weight on tirzepatide Tirzepatide: A Breakthrough Approach Losing Safely Why Am I Not Losing

For Study 3, the primary efficacy parameters were mean percent change in body weight from randomization (Week 0) to Week 72 and the percentage of patients achieving 5% weight reduction from randomization (Week 0) to Week 72

The study: strengths and red flags What I like Large-ish N with randomization and placebo control

It is not approved for the treatment of Type 1 diabetes and is not to be started by individuals with current or past pancreatitis

Symptoms may include severe abdominal pain, particularly in the upper right area, nausea, vomiting, and fever

Originally developed for managing type 2 diabetes, they are now widely recognized for their significant impact on weight reduction

2018: LY3298176 described and phase 2 trial published In late 2018, two papers formally introduced the compound